Nifty
:
22570.35
Sensex
:
74339.44
167.95 (0.75%)
486.50 (0.66%)
Nifty
Sensex
:
:
22570.35
74339.44
167.95 (0.75%)
486.50 (0.66%)

Trident Lifeline Ltd.

Pharmaceuticals & Drugs

Rating :
58/99

BSE: 543616 | NSE: Not Listed

NSE BSE
165.00
25-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  164.00
  •  166.00
  •  164.00
  •  176.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3
  •  2.97
  •  239.70
  •  123.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 189.74
  • 31.56
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 181.54
  • N/A
  • 4.04

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.48%
  • 7.30%
  • 16.39%
  • FII
  • DII
  • Others
  • 6.02%
  • 0.00%
  • 2.81%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 48.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 38.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 112.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
0.00
9.41
-100.00%
0.00
0.00
0
8.64
5.97
44.72%
8.46
8.95
-5.47%
Expenses
0.00
7.43
-100.00%
0.00
0.00
0
6.88
5.11
34.64%
6.51
7.19
-9.46%
EBITDA
0.00
1.98
-100.00%
0.00
0.00
0
1.77
0.86
105.81%
1.95
1.76
10.80%
EBIDTM
0.00%
21.03%
0.00%
0.00%
20.41%
14.48%
23.06%
19.66%
Other Income
0.00
0.39
-100.00%
0.00
0.00
0
0.33
0.01
3,200.00%
0.64
0.17
276.47%
Interest
0.00
0.13
-100.00%
0.00
0.00
0
0.10
0.08
25.00%
0.15
0.07
114.29%
Depreciation
0.00
0.13
-100.00%
0.00
0.00
0
0.13
0.09
44.44%
0.12
0.05
140.00%
PBT
0.00
2.12
-100.00%
0.00
0.00
0
1.86
0.70
165.71%
2.31
1.81
27.62%
Tax
0.00
0.10
-100.00%
0.00
0.00
0
0.46
0.00
0
0.34
-0.96
-
PAT
0.00
2.01
-100.00%
0.00
0.00
0
1.40
0.70
100.00%
1.98
2.77
-28.52%
PATM
0.00%
21.41%
0.00%
0.00%
16.23%
11.74%
23.37%
30.94%
EPS
0.00
1.75
-100.00%
0.00
0.00
0
1.22
0.88
38.64%
1.72
3.46
-50.29%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Net Sales
-
31.69
21.77
Net Sales Growth
-
45.57%
 
Cost Of Goods Sold
-
16.41
10.77
Gross Profit
-
15.29
11.00
GP Margin
-
48.25%
50.53%
Total Expenditure
-
25.43
19.06
Power & Fuel Cost
-
0.03
0.02
% Of Sales
-
0.09%
0.09%
Employee Cost
-
1.28
1.10
% Of Sales
-
4.04%
5.05%
Manufacturing Exp.
-
4.64
4.63
% Of Sales
-
14.64%
21.27%
General & Admin Exp.
-
0.91
0.81
% Of Sales
-
2.87%
3.72%
Selling & Distn. Exp.
-
1.75
1.62
% Of Sales
-
5.52%
7.44%
Miscellaneous Exp.
-
0.42
0.11
% Of Sales
-
1.33%
0.51%
EBITDA
-
6.26
2.71
EBITDA Margin
-
19.75%
12.45%
Other Income
-
1.16
0.60
Interest
-
0.48
0.13
Depreciation
-
0.36
0.20
PBT
-
6.58
2.98
Tax
-
0.56
-0.96
Tax Rate
-
8.51%
-32.21%
PAT
-
6.02
3.95
PAT before Minority Interest
-
6.02
3.95
Minority Interest
-
0.00
0.00
PAT Margin
-
19.00%
18.14%
PAT Growth
-
52.41%
 
EPS
-
5.23
3.43

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Shareholder's Funds
45.63
4.78
Share Capital
11.50
8.00
Total Reserves
34.14
-3.22
Non-Current Liabilities
1.74
0.45
Secured Loans
1.49
0.00
Unsecured Loans
0.70
1.42
Long Term Provisions
0.07
0.07
Current Liabilities
11.28
7.62
Trade Payables
4.81
5.23
Other Current Liabilities
3.38
1.29
Short Term Borrowings
2.51
0.60
Short Term Provisions
0.57
0.51
Total Liabilities
58.65
12.85
Net Block
3.11
1.43
Gross Block
4.27
2.23
Accumulated Depreciation
1.16
0.80
Non Current Assets
9.43
2.10
Capital Work in Progress
2.60
0.00
Non Current Investment
2.93
0.00
Long Term Loans & Adv.
0.78
0.67
Other Non Current Assets
0.00
0.00
Current Assets
48.87
10.72
Current Investments
0.00
0.00
Inventories
7.17
3.71
Sundry Debtors
12.12
4.97
Cash & Bank
13.77
0.16
Other Current Assets
15.81
0.09
Short Term Loans & Adv.
13.09
1.79
Net Current Assets
37.60
3.10
Total Assets
58.66
12.85

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Cash From Operating Activity
-17.44
-0.21
PBT
6.58
2.98
Adjustment
0.08
0.33
Changes in Working Capital
-23.56
-3.67
Cash after chg. in Working capital
-16.90
-0.36
Interest Paid
0.00
0.00
Tax Paid
-0.54
0.00
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.14
Cash From Investing Activity
-6.94
-0.45
Net Fixed Assets
-2.27
Net Investments
-3.99
Others
-0.68
Cash from Financing Activity
38.00
0.80
Net Cash Inflow / Outflow
13.62
0.14
Opening Cash & Equivalents
0.16
0.01
Closing Cash & Equivalent
13.77
0.16

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Book Value (Rs.)
39.38
5.93
ROA
16.83%
30.72%
ROE
24.05%
83.23%
ROCE
24.32%
43.21%
Fixed Asset Turnover
9.75
9.76
Receivable days
98.38
83.27
Inventory Days
62.65
62.24
Payable days
111.70
177.25
Cash Conversion Cycle
49.33
-31.74
Total Debt/Equity
0.12
0.52
Interest Cover
14.66
24.72

Annual Reports:

FY 2023
FY 2022

News Update:


  • Trident Lifeline gets nod to incorporate wholly owned subsidiary
    8th Apr 2024, 09:50 AM

    This entity will be positioned as a company for all types of cosmetic and herbal products

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.